PETS logo

PETMED EXPRESS INC

PETSNASDAQ
πŸ† #4544 by market capEarnings Nov 11US Equity
$1.19β–² $0.01 (+0.85%)
πŸŒ… Pre-market$1.18β–Ό 1.26%Regular close Β· extended-hours price shown
πŸ””
Track PETS
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.8%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$26M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-21.1%
Declining
πŸ“ŠGross Margin
23.7%
Moderate
πŸ’΅FCF Margin
-16.4%
Thin
βš–οΈP/S Ratio
0.2x
Cheap
Otter Score
β€”
Insufficient data
No chart data available for PETS.

Trading Snapshot

Day Range
$1.18 – $1.20
52-Week Range
$1.15 – $4.10
Volume (shares)
18,815
Avg Volume (shares)
β€”
Shares Outstanding
21.7M
Next Earnings
2026-11-11

Fundamentals Snapshot

Annual Revenue
$179M
Last Q Revenue
$41M
P/E Ratio
-0.9
P/S Ratio
0.2x
EPS (TTM)
$-1.35
Dividend Yield
0.00%
Dilution (1yr)
+3.2%
PETS logo

PETMED EXPRESS INC

PETS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$179Mβ–Ό βˆ’21.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
22.8%β–Ό βˆ’25.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$31Mβ–² +1953.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$33Mβ–² +8256.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
21.7Mβ–² +3.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$13Mβ–Ό βˆ’$14M YoY
StockOtter Β· stockotter.space

About PETMED EXPRESS INC

PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100

Analyst Ratings

β“˜
Consensus
Sell
6 analysts
Strong Buy0
Buy0
Hold2
Sell2
Strong Sell2
Ratings as of Oct 2026

Latest News & Updates

GlobeNewsWireΒ·1d ago

PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026

DELRAY BEACH, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the second quarter fiscal year

GlobeNewsWireΒ·26d ago

PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DELRAY BEACH, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that PetMeds recently granted equity awards previously approved by i

GlobeNewsWireΒ·Sep 21

PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director

Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Human Capital Strategy to Support Strategic Growth and Operational Execution Dr. Elkeles Brings Deep Experience and Proven Track Record in Shaping Hum

GlobeNewsWireΒ·Sep 17

PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition

Justin Mennen to Succeed Leslie C.G. Campbell as Chair of the Board Following Her Retirement Justin Mennen to Succeed Leslie C.G. Campbell as Chair of the Board Following Her Retirement

GlobeNewsWireΒ·Sep 14

PetMeds Appoints Andrew Parry as Chief Technology Officer

DELRAY BEACH, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced the appointment of Andrew Parry as Chief Technology Officer, effect

Defense WorldΒ·Sep 10

Head-To-Head Contrast: PetMed Express (NASDAQ:PETS) versus Carvana (NYSE:CVNA)

Carvana (NYSE: CVNA - Get Free Report) and PetMed Express (NASDAQ: PETS - Get Free Report) are both consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the stre